n,n-dimethylarginine has been researched along with Cardiomegaly in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, LJ; Peng, XD; Sun, JC; Tan, X; Wang, WZ; Yang, RH | 1 |
| Biri, B; Cziraki, A; Keki, S; Koller, A; Nemeth, Z; Szabados, S | 1 |
| Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ | 1 |
3 other study(ies) available for n,n-dimethylarginine and Cardiomegaly
| Article | Year |
|---|---|
Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide.
Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Cardiomegaly; Down-Regulation; Gene Knockdown Techniques; Losartan; Male; Myocytes, Cardiac; Nitric Oxide; Nuclear Factor 90 Proteins; Rats, Sprague-Dawley | 2019 |
Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.
Topics: Adult; Arginine; Cardiomegaly; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Pericardial Fluid; Ventricular Remodeling | 2015 |
Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.
Topics: Abietanes; Animals; Arginine; Cardiomegaly; Cardiovascular Agents; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type III; Cystatin C; Disease Models, Animal; Hypertension; Male; Myocardium; NADPH Oxidase 4; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Troponin I; Wnt Signaling Pathway | 2017 |